The DOI matches its Crossref record; 84 of the 85 references it cites were found in a registry or an index.
The Origin and Evolution of Mutations in Acute Myeloid Leukemia
Open accessAbstract
Most mutations in cancer genomes are thought to be acquired after the initiating event, which may cause genomic instability and drive clonal evolution. However, for acute myeloid leukemia (AML), normal karyotypes are common, and genomic instability is unusual. To better understand clonal evolution in AML, we sequenced the genomes of M3-AML samples with a known initiating event (PML-RARA) versus the genomes of normal karyotype M1-AML samples and the exomes of hematopoietic stem/progenitor cells (HSPCs) from healthy people. Collectively, the data suggest that most of the mutations found in AML genomes are actually random events that occurred in HSPCs before they acquired the initiating mutation; the mutational history of that cell is "captured" as the clone expands. In many cases, only one or two additional, cooperating mutations are needed to generate the malignant founding clone. Cells from the founding clone can acquire additional cooperating mutations, yielding subclones that can contribute to disease progression and/or relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mice lacking Msh2, the key component of both the MutSα and MutSβ complexes that mediate DNA MMR, display a genetic phenotype that closely mimics the spectrum of mutations found in aging human HSCs and in patients with myeloid leukemia (transition mutations and small insertions and deletions) 26, 27.”
From Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia (2015) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies in patients with AML have confirmed the functional importance and clinical significance of preleukemic stem cell populations as the cellular origin of leukemia-initiating cells in human disease27, 48.”
From Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia (2015) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The study of somatic mutations with standard whole-genome sequencing requires isolating clonal groups of cells recently derived from a single cell8,13,14.”
From Somatic mutation rates scale with lifespan across mammals (2022) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Hematopoietic stem cells (HSCs) randomly acquire somatic mutations with age (1).”
From Txnip Enhances Fitness of Dnmt3a -Mutant Hematopoietic Stem Cells via p21 (2022) · cites this paper as [1]
In the citing paper
“Interestingly, during human aging, mutations accumulate in the genome of blood cells and C-to-T mutations are the most prevalent (Welch et al., 2012).”
From The Aging Epigenome (2016) · cites this paper as Welch et al., 2012
In the citing paper
“As each HSC acquires ~1 exonic mutation per decade of life 3,”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [3]
In the citing paper
“Like most cancers, AML generally results from several driver mutations that occur sequentially in the same clone over time 3.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [3]
In the citing paper
“Aging is associated with a steady increase in the number of somatic mutations in virtually all tissues 1–5.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [3]
In the citing paper
“We recently reported that individual HSPCs accumulate somatic mutations as a function of age, such that by age 50, there are on average 5 coding gene mutations per HSPC11.”
From Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia (2015) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L. S., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,669
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingPreprint
Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,931
Self-citationRecurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219
Self-citation
Flagged first, then by citations
1 of the 85 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Ding, L., Ley, T.J., Larson, D.E., Miller, C.A., Koboldt, D.C., Welch, J.S., Ritchey, J.K., Young, M.A., Lamprecht, T., McLellan, M.D., et al. (2012). Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481, 506–510. · DOI · Paper page
- Larson, D.E., Harris, C.C., Chen, K., Koboldt, D.C., Abbott, T.E., Dooling, D.J., Ley, T.J., Mardis, E.R., Wilson, R.K., and Ding, L. (2012). SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics 28, 311–317. · DOI
- Ley, T.J., Mardis, E.R., Ding, L., Fulton, B., McLellan, M.D., Chen, K., Dooling, D., Dunford-Shore, B.H., McGrath, S., Hickenbotham, M., et al. (2008). DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456, 66–72. · DOI
- Mardis, E.R., Ding, L., Dooling, D.J., Larson, D.E., McLellan, M.D., Chen, K., Koboldt, D.C., Fulton, R.S., Delehaunty, K.D., McGrath, S.D., et al. (2009). Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058–1066. · DOI · Paper page
Cited by
Sorted by citations
Items 901–1,000 of 1,001
DOT1L inhibitors block abnormal self-renewal induced by cohesin loss
Heimbruch, K. E., Fisher, J. B., Stelloh, C. T., Phillips, E., Reimer, M. H., Wargolet, A. J., Meyer, A. E., Pulakanti, K., Viny, A. D., Loppnow, J. J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-86646-9 · Cited by 14
Epigenetics in a Spectrum of Myeloid Diseases and Its Exploitation for Therapy
Maher, M., Diesch, J., Pannérer, M.-M. L., & Buschbeck, M. (2021) · Cancers · doi:10.3390/cancers13071746 · Cited by 14
Clinical applications of cell-free DNA-based liquid biopsy analysis
Yazaki, S., Tokura, M., Aiba, H., Kojima, Y., & Shiraishi, K. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102519 · Cited by 13
Palma, A., Iannuccelli, M., Rozzo, I., Licata, L., Perfetto, L., Massacci, G., Castagnoli, L., Cesareni, G., & Sacco, F. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020117 · Cited by 15
Ambayya, A., Moorman, A. V., Sathar, J., Eswaran, J., Sulong, S., & Hassan, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010258 · Cited by 13
A case of refractory systemic lupus erythematosus with monocytosis exhibiting somatic KRAS mutation
Law, S.-M., Akizuki, S., Morinobu, A., & Ohmura, K. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00195-w · Cited by 14
Biology and Therapeutic Properties of Mesenchymal Stem Cells in Leukemia
Wu, C.-H., Weng, T.-F., Li, J.-P., & Wu, K.-H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052527 · Cited by 13
Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges
Alvarez, N. D. D., Martı́n, A., Dorado, S., Colmenares, R., Rufián, L., Rodríguez, M., Giménez, A., Carneros, L., Sanchez, R., Carreño‐Tarragona, G., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1252258 · Cited by 13
Mesenchymal stem cells in the bone marrow microenvironment: a double-edged sword for AML
Saadh, M. J., Fard, N. T., Hussein, A., Mirzazadeh, A., Siavashi, M., Seyedmoharrami, F., Noroozi, S., & Samarkhazan, H. S. (2025) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-025-06244-4 · Cited by 13
Lucena-Araujo, A. R., Kim, H. T., Jácomo, R. H., Melo, R. A. M., Bittencourt, R., Pasqüini, R., Pagnano, K. B. B., Fagundes, E. M., Chauffaille, M. D. L., CHIATTONE, C. S., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.12921 · Cited by 13
Relapse assessment following allogeneic SCT in patients with MDS and AML
Christopeit, M., Kröger, N. M., Haferlach, T., & Bacher, U. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2046-8 · Cited by 13
Molecular Profiling: A Case ofZBTB16-RARAAcute Promyelocytic Leukemia
Langabeer, S. E., Preston, L., Kelly, J., Goodyer, M. J., Elhassadi, E., & Hayat, A. (2017) · Case Reports in Hematology · doi:10.1155/2017/7657393 · Cited by 13
Novel single-cell technologies in acute myeloid leukemia research
Gupta, S. D., & Sachs, Z. (2017) · Translational research · doi:10.1016/j.trsl.2017.07.007 · Cited by 14
Enhanced risk of cancer in companion animals as a response to the longevity
Tanaka, M., Yamaguchi, S., & Iwasa, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-75684-4 · Cited by 13
Assessing Limit of Detection in Clinical Sequencing
Starks, E. R., Swanson, L., Docking, R., Bosdet, I., Munro, S., Moore, R. A., & Karsan, A. (2021) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.12.010 · Cited by 13
Characteristics of Cohesin Mutation in Acute Myeloid Leukemia and Its Clinical Significance
Han, C., Gao, X., Li, Y., Zhang, J., Yang, E., Zhang, L., & Yu, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.579881 · Cited by 15
Autophagy in acute myeloid leukemia: a paradoxical role in chemoresistance
Khan, A., Singh, V. K., Thakral, D., & Gupta, R. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02804-z · Cited by 15
Accurate Identification of Subclones in Tumor Genomes
Ahmadinejad, N., Troftgruben, S., Wang, J., Chandrashekar, P. B., Dinu, V., Maley, C. C., & Liu, L. (2022) · Molecular Biology and Evolution · doi:10.1093/molbev/msac136 · Cited by 13
Game of clones: Battles in the field of carcinogenesis
Rahal, Z., Sinjab, A. F., Wistuba, I. I., & Kadara, H. N. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108251 · Cited by 14
Towards an accurate and robust analysis pipeline for somatic mutation calling
Jin, J., Chen, Z., Liu, J., Du, H., & Zhang, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.979928 · Cited by 13
Weber, S., Haferlach, T., Alpermann, T., Perglerová, K., Schnittger, S., Haferlach, C., & Kern, W. (2016) · British Journal of Haematology · doi:10.1111/bjh.14343 · Cited by 13
Mutational Spectrum Of Adult T-ALL
Neumann, M., Heesch, S., Vosberg, S., Schlee, C., Schwartz, S., Gökbuget, N., Hoelzer, D. F., Graf, A., Krebs, S., Blum, H., et al. (2013) · Blood · doi:10.1182/blood.v122.21.828.828 · Cited by 13
Walter, C., Pozzorini, C., Reinhardt, K., Geffers, R., Xu, Z., Reinhardt, D., Neuhoff, N. V., & Hanenberg, H. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26848 · Cited by 13
DeStefano, C. B., & Hourigan, C. S. (2018) · Therapeutic Advances in Hematology · doi:10.1177/2040620718761778 · Cited by 13
Yokoyama, K., Shimizu, E., Yokoyama, N., Nakamura, S., Kasajima, R., Ogawa, M., Takei, T., Ito, M., Kobayashi, A., Yamaguchi, R., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017010744 · Cited by 13
Fowles, J. S., How, J., Allen, M. J., & Oh, S. T. (2019) · Leukemia · doi:10.1038/s41375-018-0349-9 · Cited by 13
Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges
Caponetti, G. C., & Bagg, A. (2020) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13284 · Cited by 14
Liu, Y., Gu, Z., Cao, H., Kaphle, P., Lyu, J., Zhang, Y., Hu, W., Chung, S. S., Dickerson, K. E., & Xu, J. (2021) · Nature Communications · doi:10.1038/s41467-021-26582-4 · Cited by 13
Mutations in epigenetic modifiers in acute myeloid leukemia and their clinical utility
Hou, H., & Tien, H. (2016) · Expert Review of Hematology · doi:10.1586/17474086.2016.1144469 · Cited by 13
Genomic Profiling and Predicting Treatment Response in Acute Myeloid Leukemia
Isidori, A., Loscocco, F., Curti, A., Amadori, S., & Visani, G. (2019) · Pharmacogenomics · doi:10.2217/pgs-2018-0202 · Cited by 13
The Crossroads of Clonal Evolution, Differentiation Hierarchy, and Ontogeny in Leukemia Development
Sturgeon, C. M., Wagenblast, E., Izzo, F., & Papapetrou, E. P. (2024) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-24-0235 · Cited by 12
DNA methylation drives hematopoietic stem cell aging phenotypes after proliferative stress
Yanai, H., McNeely, T. L., Ayyar, S., Leone, M., Zong, L., Park, B., & Beerman, I. (2024) · GeroScience · doi:10.1007/s11357-024-01360-4 · Cited by 14
Accelerating CAR-T Cell Therapies with Small-Molecule Inhibitors
Mestermann, K., Garitano-Trojaola, A., & Hudecek, M. (2024) · BioDrugs · doi:10.1007/s40259-024-00688-9 · Cited by 13
Hematopoiesis Lineage Tree Uprooted: Every Cell Is a Rainbow
Hirschi, K. K., Nicoli, S., & Walsh, K. X. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.03.020 · Cited by 15
MLLT10 in benign and malignant hematopoiesis
Deutsch, J., & Heath, J. L. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.06.002 · Cited by 12
Boila, L. D., & Sengupta, A. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.09.189 · Cited by 12
Glasdegib in newly diagnosed acute myeloid leukemia
Sarkaria, S. M., & Heaney, M. L. (2021) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2021.1891885 · Cited by 12
Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq
Saygin, C., Hu, E. Y., Zhang, P., Sher, S., Lozanski, A., Doong, T.-J., Nicolet, D., Orwick, S. J., Labanowska, J. M., Skinner, J. N., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01295-1 · Cited by 12
Self-citationRivas, M. A., Durmaz, C., Kloetgen, A., Chin, C. R., Chen, Z., Bhinder, B., Koren, A., Viny, A. D., Scharer, C. D., Boss, J. M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688493 · Cited by 12
Shabashvili, D. E., Feng, Y., Kaur, P., Venugopal, K., & Guryanova, O. A. (2022) · Experimental Hematology · doi:10.1016/j.exphem.2022.03.008 · Cited by 14
Biavasco, F., & Zeiser, R. (2022) · International Journal of Hematology · doi:10.1007/s12185-022-03352-6 · Cited by 12
Qiao, W., Young, E. J., Chun, F., Liu, S., Jin, J., Noor, L. Z., Hernandez, C. M. R., Borthakur, G. M., Gorlova, O. Y., & Afshar‐Kharghan, V. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00309-7 · Cited by 12
Song, X., Ye, P., Wang, X., Chen, Q., Lan, X., & Shi, F. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-03065-6 · Cited by 12
Older patients/older donors: choosing wisely
Artz, A. S. (2013) · Hematology · doi:10.1182/asheducation-2013.1.70 · Cited by 12
Myelodysplastic features in a patient with germline CEBPA-mutant acute myeloid leukaemia
Yan, B., Ng, C., Moshi, G. B., Ban, K. H.-K., Lee, P.-L., Seah, E., Chiu, L., Koay, E. S., Liu, T.-C., Ng, C. H., et al. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2016-203672 · Cited by 12
Valera, A., Epistolio, S., Colomo, L., Riva, A., Balagué, O., Dlouhy, I., Tzankov, A., Bühler, M. M., Haralambieva, E., Campo, E., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.71 · Cited by 12
Fernandez‐Pol, S., Ma, L., Ohgami, R. S., & Arber, D. A. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.100 · Cited by 12
Impact of age on genetics and treatment efficacy in follicular lymphoma
Alig, S., Jurinović, V., Pastore, A., Bararia, D., Haebe, S., Hellmuth, J. C., Kridel, R., Gascoyne, R. D., Schmidt, C., Zoellner, A., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.187773 · Cited by 12
Tumor heterogeneity of acute myeloid leukemia: insights from single-cell sequencing
Chen, A., Hu, S., & Wang, Q. (2019) · Blood Science · doi:10.1097/bs9.0000000000000015 · Cited by 12
ETV6 and NOTCH1 germline variants in adult acute leukemia
Dirsė, V., Norvilas, R., Gineikienė, E., Matuzevičienė, R., Griškevičius, L., & Preikšaitienė, E. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1359742 · Cited by 12
Kaphan, É., Bettega, F., Forcade, É., Labussière‐Wallet, H., Fegueux, N., Robin, M., de Latour, R. P., Huynh, A., Lapierre, L., Berceanu, A., et al. (2023) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2023.02.020 · Cited by 11
Shahid, S., Ceglia, N., Luduec, J.-B. L., McPherson, A., Spitzer, B. G., Kontopoulos, T., Bojilova, V., Panjwani, M. K., Roshal, M., Shah, S. P., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022009468 · Cited by 11
Concise Review: Induced Pluripotent Stem Cells as New Model Systems in Oncology
Laplane, L., Beke, A., Vainchenker, W., & Solary, É. (2015) · Stem Cells · doi:10.1002/stem.2099 · Cited by 11
Acute Myeloid Leukemia With Recurrent Genetic Abnormalities Other Than Translocations
Lin, P., & Falini, B. (2015) · American Journal of Clinical Pathology · doi:10.1309/ajcp97bjbevzeuin · Cited by 11
Merker, J. D., Roskin, K. M., Ng, D., Pan, C., Fisk, D. G., King, J. M., Hoh, R. A., Stadler, M. R., Okumoto, L. M., Abidi, P., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.092379 · Cited by 11
Graubert, T. A., Brunner, A. M., & Fathi, A. T. (2014) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2014.34.e334 · Cited by 12
Self-citationIs lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?
Brown, G., & Sánchez-Garcı́a, I. (2015) · Oncotarget · doi:10.18632/oncotarget.6145 · Cited by 12
Avancées thérapeutiques majeures et nouvelles perspectives en onco-hématologie
Bay, J., Guièze, R., Ravinet, A., Lemal, R., Xhaard, A., Bailly, S., Moluçon‐Chabrot, C., Hermet, É., Biau, J., Verrelle, P., et al. (2013) · Bulletin du Cancer · doi:10.1684/bdc.2013.1751 · Cited by 11
Atypical CML- the role of morphology and precision genomics
Lasho, T. L. (2019) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2019.101133 · Cited by 11
Guo, X., Li, J., Xue, J., Fenech, M. F., & Wang, X. (2021) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2021.108389 · Cited by 12
Alarcón‐Sánchez, B. R., Pérez‐Carreón, J. I., Villa‐Treviño, S., & Arellanes‐Robledo, J. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114818 · Cited by 12
Kumar, P., Zhang, N., Lee, J., Cheng, H., Kurtz, K. J., Conneely, S. E., Sasidharan, R., Rau, R. E., & Pati, D. (2023) · Stem Cells · doi:10.1093/stmcls/sxad058 · Cited by 11
Clinical and Therapeutic Implications of Clonal Hematopoiesis
Petrone, G. E. M., Turker, I., Natarajan, P., & Bolton, K. L. (2024) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-120722-100409 · Cited by 11
A Novel Tandem Duplication Assay to Detect Minimal Residual Disease in FLT3/ITD AML
Lin, M., Tseng, L., Dudley, J. C., Riel, S., Tsai, H. K., Zheng, G., Pratz, K. W., Levis, M. J., & Gocke, C. D. (2015) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-015-0170-3 · Cited by 11
Link, D. C. (2012) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2012.10.002 · Cited by 11
Self-citationMeasurement of Residual Disease in Acute Myeloid Leukemia
Vedula, R. S., & Lindsley, R. C. (2017) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-017-0428-4 · Cited by 11
Strugov, V. V., Stadnik, E., Virts, Y., Andreeva, T., & Zaritskey, A. Y. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3409-3 · Cited by 11
Current Aspects of Clonal Hematopoiesis: Implications for Clinical Diagnosis
Karner, K. H., George, T. I., & Patel, J. L. (2019) · Annals of Laboratory Medicine · doi:10.3343/alm.2019.39.6.509 · Cited by 11
Autophagy and senescence: Insights from normal and cancer stem cells
Talukdar, S., Das, S. K., Emdad, L., & Fisher, P. B. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.005 · Cited by 12
Enhancer rewiring in tumors: an opportunity for therapeutic intervention
Richart, L., Bidard, F., & Margueron, R. (2021) · Oncogene · doi:10.1038/s41388-021-01793-7 · Cited by 12
Genetic diversity within leukemia-associated immunophenotype-defined subclones in AML
Tiso, F., Koorenhof-Scheele, T. N., Huys, E., Martens, J. H. A., de Graaf, A. O., van der Reijden, B. A., Langemeijer, S. M. C., Preijers, F. W. M. B., Kroeze, L. I., & Jansen, J. H. (2022) · Annals of Hematology · doi:10.1007/s00277-021-04747-x · Cited by 11
Targeted Therapy of FLT3 in Treatment of AML—Current Status and Future Directions
Engen, C., Wergeland, L., Skavland, J., & Gjertsen, B. T. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041466 · Cited by 11
Mutant TP53 disrupts age-related accumulation patterns of somatic mutations in multiple cancer types
Zhang, W., Flemington, E. K., & Zhang, K. (2016) · Cancer Genetics · doi:10.1016/j.cancergen.2016.07.001 · Cited by 11
Epigenetic Reprogramming in Cancer
Lindroth, A. M., Park, Y. J., & Plass, C. (2014) · Epigenetics and human health · doi:10.1007/978-3-642-31974-7_9 · Cited by 12
A case of me: clinical cancer sequencing and the future of precision medicinePreprint
Wartman, L. D. (2015) · Molecular Case Studies · doi:10.1101/mcs.a000349 · Cited by 11
Self-citationSim, H., Park, H. J., Park, G., Kim, Y. J., Park, W., Lee, S., & Choi, M. (2024) · eLife · doi:10.7554/elife.96951 · Cited by 12
Cacic, A. M., Schulz, F. I., Germing, U., Dietrich, S., & Gattermann, N. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1303785 · Cited by 12
Cull, A. H., Kent, D. G., & Warren, A. J. (2024) · Blood · doi:10.1182/blood.2023019986 · Cited by 10
The emerging role of clonal haematopoiesis in the pathogenesis of dilated cardiomyopathy
Verdonschot, J. A. J., Fuster, J. J., Walsh, K. X., & Heymans, S. R. B. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae682 · Cited by 14
Somatic mutations reveal the ontogeny of microglia in human ageing
Belk, J. A., Zhang, Y., Reilly, E., Shi, Q., Liu, D. D., Womack-Gambrel, N., van der Linde, M., Ma, L., Paul, D., Enciso, A. M., et al. (2026) · Nature · doi:10.1038/s41586-026-10939-0 · Cited by 13
Genetic mutations in acute myeloid leukemia that influence clinical decisions
Chung, S. S. (2014) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000024 · Cited by 10
Ronchini, C., Brozzi, A., Riva, L., Luzi, L., Gruszka, A., Melloni, G. E. M., Scanziani, E., Dharmalingam, G., Mutarelli, M., Belcastro, V., et al. (2016) · Leukemia · doi:10.1038/leu.2016.386 · Cited by 10
A personalized approach to acute myeloid leukemia therapy: current options
Illangeswaran, R. S. S., Das, S., Paul, D. Z., Mathews, V., & Balasubramanian, P. (2019) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s168267 · Cited by 10
Polyclonal evolution of Fanconi anemia to MDS and AML revealed at single cell resolution
Chang, L., Cui, Z., Shi, D., Chu, Y., Wang, B., Wan, Y., Ma, Q., Zhang, R., Li, H., Cheng, X., et al. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00319-5 · Cited by 12
Magalhães, E. S. D. C., Hubner, S. E., Brown, B. D., Qiu, Y., & Kornblau, S. M. (2024) · Leukemia · doi:10.1038/s41375-024-02208-8 · Cited by 10
Cellular origin of prognostic chromosomal aberrations in AML patients
Mora-Jensen, H. I., Jendholm, J., Rapin, N., Andersen, M. K., Roug, A. S., Bagger, F. O., Bullinger, L., Winther, O., Borregaard, N., Porse, B. T., et al. (2015) · Leukemia · doi:10.1038/leu.2015.30 · Cited by 10
Matsushita, H., Yahata, T., Sheng, Y., Nakamura, Y., Muguruma, Y., Matsuzawa, H., Tanaka, M., Hayashi, H., Sato, T., Damdinsuren, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111082 · Cited by 10
Inter-Laboratory Evaluation of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia
Haslam, K., Catherwood, M. A., Dobbin, E., Sproul, A. M., Langabeer, S. E., & Mills, K. (2016) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0222-3 · Cited by 10
Knorr, K. L. B., Finn, L. E., Smith, B. D., Hess, A. D., Foran, J. M., Karp, J. E., & Kaufmann, S. H. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2016-0034 · Cited by 10
Kakadia, P. M., de Water, N. V., Browett, P., & Bohlander, S. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-31503-5 · Cited by 10
Molecular/Cytogenetic Education for Hematopathology Fellows
Beck, R. C., Kim, A. S., Goswami, R. S., Weinberg, O. K., Yeung, C. C. S., & Ewalt, M. D. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa038 · Cited by 10
Future perspectives from lung cancer pre-clinical models: new treatments are coming?
Bersani, F., Morena, D., Picca, F., Morotti, A., Tabbò, F., Bironzo, P., Righi, L., & Taulli, R. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-189 · Cited by 10
Germline DNMT3A mutation in familial acute myeloid leukaemia
Dinardo, C. D., Beird, H. C., Estecio, M. R., Hardikar, S., Takahashi, K., Bannon, S. A., Borthakur, G. M., Jabbour, E. J., Gumbs, C. E., Khoury, J. D., et al. (2020) · Epigenetics · doi:10.1080/15592294.2020.1809871 · Cited by 10
The evolution of leukaemia from pre‐leukaemic and leukaemic stem cells
Shlush, L. I., & Feldman, T. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13236 · Cited by 10
Hinai, A. S. A. A., Grob, T., Rijken, M., Kavelaars, F. G., Zeilemaker, A., Erpelinck-Verschueren, C. A. J., Sanders, M. A., Löwenberg, B., Jongen‐Lavrencic, M., & Valk, P. J. M. (2021) · Leukemia · doi:10.1038/s41375-021-01155-y · Cited by 10
Clonal haematopoiesis of emerging significance
Hammond, D. E., & Loghavi, S. (2021) · Pathology · doi:10.1016/j.pathol.2021.02.005 · Cited by 10
The role of exosomes in the stemness maintenance and progression of acute myeloid leukemia
Li, Q., Wang, M., & Liu, L. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115539 · Cited by 11
The Use of Molecular Genetics to Refine Prognosis in Acute Myeloid Leukemia
Bhatnagar, B., & Garzon, R. (2014) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-014-0208-3 · Cited by 10
Wang, M., He, N., Tian, T., Liu, L., Yu, S., & Ma, D. (2014) · BioMed Research International · doi:10.1155/2014/485645 · Cited by 10
Clonal evolution of acute myeloid leukemia highlighted by latest genome sequencing studies
Zhang, X., Lv, D., Zhang, Y., Liu, Q., & Li, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.10850 · Cited by 11
Metadata
- Authors
- Welch, J. S., Ley, T. J., Link, D. C., Miller, C. A., Larson, D. E., Koboldt, D. C., Wartman, L. D., Lamprecht, T. L., Liu, F., Xia, J., Kandoth, C., Fulton, R. S., McLellan, M. D., Dooling, D. J., Wallis, J. W., Chen, K., Harris, C. C., Schmidt, H. K., Kalicki-Veizer, J. M., Lu, C., Zhang, Q., Lin, L., O’Laughlin, M. D., McMichael, J. F., Delehaunty, K. D., Fulton, L. A., Magrini, V. J., McGrath, S. D., Demeter, R. T., Vickery, T. L., Hundal, J., Cook, L. L., Swift, G. W., Reed, J. P., Alldredge, P. A., Wylie, T. N., Walker, J. R., Watson, M. A., Heath, S. E., Shannon, W. D., Varghese, N., Nagarajan, R., Payton, J. E., Baty, J. D., Kulkarni, S., Klco, J. M., Tomasson, M. H., Westervelt, P., Walter, M. J., Graubert, T. A., DiPersio, J. F., Ding, L., Mardis, E. R., & Wilson, R. K.
- Affiliations
- Washington University in St. Louis (US)
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Ley, Timothy J.
- ORCID
- Welch, John S.
- Ley, Timothy J.
- Link, Daniel C.
- Miller, Christopher A.
- Larson, David E.
- Koboldt, Daniel C.
- Wartman, Lukas D.
- Liu, Fulu
- Xia, Jun
- Kandoth, Cyriac
- Fulton, Robert S.
- McLellan, Michael D.
- Chen, Ken
- Lu, Charles
- Lin, Ling
- O’Laughlin, Michelle D.
- McMichael, Joshua F.
- Magrini, Vincent J.
- McGrath, Sean D.
- Vickery, Tammi L.
- Hundal, Jasreet
- Cook, Lisa L.
- Wylie, Todd N.
- Walker, Jason R.
- Watson, Mark A.
- Heath, Sharon E.
- Payton, Jacqueline E.
- Kulkarni, Shashikant
- Klco, Jeffery M.
- Tomasson, Michael H.
- Walter, Matthew J.
- Graubert, Timothy A.
- DiPersio, John F.
- Ding, Li
- Mardis, Elaine R.
- Wilson, Richard K.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 150
- Issue
- 2
- Pages
- 264-278
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC3407563
- OpenAlex
- W2012753533
- Cited by
- 1,575
- References
- 85
- Citations by year
- 2026: 31 · 2025: 60 · 2024: 68 · 2023: 87 · 2022: 95 · 2021: 125 · 2020: 128 · 2019: 134 · 2018: 116 · 2017: 120 · 2016: 130 · 2015: 141 · 2014: 184 · 2013: 134 · 2012: 19
- FWCI
- 101.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 384 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R00HL103975, K99HL103975)
- National Human Genome Research Institute (U54HG003079)
- National Cancer Institute (P30 CA 91842, R01CA083962, P01CA101937, P30CA091842)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- acute myeloid leukemia, clonal evolution, hematopoietic stem and progenitor cells, PML-RARA fusion, normal karyotype, cooperating mutations, subclonal evolution, disease progression, relapse, genomic instability
- MeSH terms
- Adult, Aged, DNA Mutational Analysis, Female, Hematopoietic Stem Cells, Humans, Male, Middle Aged, Mutation, Recurrence, Skin, Leukemia, Myeloid, Acute, Oncogene Proteins, Fusion, Disease Progression, Genome-Wide Association Study, Young Adult, Clonal Evolution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
